Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation time
- 1 July 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 352 (1) , 59-63
- https://doi.org/10.1016/s0014-2999(98)00339-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antithrombotic effects of YM‐60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding timeBritish Journal of Pharmacology, 1998
- YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding timeEuropean Journal of Pharmacology, 1997
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Interactions of Warfarin with Drugs and FoodAnnals of Internal Medicine, 1994
- Direct thrombin inhibitors in cardiovascular medicine.Circulation, 1994
- Importance of platelets in experimental venous thrombosis in the ratBlood, 1992
- Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- Thrombin Interactions with Platelet Membrane ProteinsaAnnals of the New York Academy of Sciences, 1986
- Optimization of conditions for the catalytic effect of the factor IXa - Factor VIII complexThrombosis Research, 1979